Grimes & Company, Inc. Gilead Sciences, Inc. Transaction History

Grimes & Company, Inc.

$3.22 Billion
Q1 2024

A detailed history of Grimes & Company, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Grimes & Company, Inc. holds 17,406 shares of GILD stock, worth $1.18 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

17,406

Previous 17,044 2.12%

Holding current value

$1.18 Million

Previous $1.38 Million 7.68%

% of portfolio

0.04%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$71.58 - $87.29 $25,911 - $31,598	362 Added 2.12%	17,406 $1.27 Million
Q4 2023 Jan 24, 2024	BUY	$73.27 - $83.09 $7,253 - $8,225	99 Added 0.58%	17,044 $1.38 Million
Q3 2023 Oct 19, 2023	BUY	$73.94 - $80.67 $10,721 - $11,697	145 Added 0.86%	16,945 $1.27 Million
Q2 2023 Jul 19, 2023	BUY	$76.01 - $86.7 $1,368 - $1,560	18 Added 0.11%	16,800 $1.29 Million
Q1 2023 Apr 20, 2023	SELL	$77.31 - $88.08 $19,327 - $22,020	-250 Reduced 1.47%	16,782 $1.39 Million

Q4 2022 Jan 25, 2023	SELL	$62.32 - $89.47 $1,807 - $2,594	-29 Reduced 0.17%	17,032 $0
Q3 2022 Oct 28, 2022	BUY	$59.54 - $68.01 $6,132 - $7,005	103 Added 0.61%	17,061 $1.05 Million
Q2 2022 Jul 22, 2022	SELL	$57.72 - $65.01 $1,558 - $1,755	-27 Reduced 0.16%	16,958 $1.05 Million
Q1 2022 May 06, 2022	BUY	$57.92 - $72.58 $18,824 - $23,588	325 Added 1.95%	16,985 $1.01 Million
Q4 2021 Feb 01, 2022	BUY	$64.88 - $73.64 $3,892 - $4,418	60 Added 0.36%	16,660 $1.21 Million
Q3 2021 Nov 08, 2021	BUY	$67.69 - $73.03 $744 - $803	11 Added 0.07%	16,600 $1.16 Million
Q2 2021 Aug 04, 2021	BUY	$63.47 - $69.35 $698 - $762	11 Added 0.07%	16,589 $1.14 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $132,900 - $151,638	2,215 Added 15.42%	16,578 $1.07 Million
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $9,460 - $10,779	-167 Reduced 1.15%	14,363 $837,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $2,297 - $2,888	-37 Reduced 0.25%	14,530 $918,000
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $17,072 - $19,824	-236 Reduced 1.59%	14,567 $1.12 Million
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $21,231 - $27,194	339 Added 2.34%	14,803 $1.11 Million
Q4 2019 Feb 05, 2020	BUY	$61.62 - $67.78 $113,997 - $125,393	1,850 Added 14.67%	14,464 $940,000
Q3 2019 Nov 05, 2019	SELL	$62.51 - $69.0 $10,876 - $12,006	-174 Reduced 1.36%	12,614 $799,000
Q2 2019 Jul 30, 2019	SELL	$61.87 - $69.38 $26,727 - $29,972	-432 Reduced 3.27%	12,788 $864,000
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $22,823 - $25,568	-365 Reduced 2.69%	13,220 $859,000
Q4 2018 Feb 01, 2019	BUY	$60.54 - $79.0 $544 - $711	9 Added 0.07%	13,585 $850,000
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $11,048 - $12,232	-155 Reduced 1.13%	13,576 $1.05 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $102,250 - $119,271	-1,576 Reduced 10.3%	13,731 $973,000
Q1 2018 May 07, 2018	BUY	$72.84 - $88.8 $872,987 - $1.06 Million	11,985 Added 360.78%	15,307 $1.15 Million
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $236,360 - $277,453	3,322	3,322 $238,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Account

Grimes & Company, Inc. Gilead Sciences, Inc. Transaction History